Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility...
Patient Care
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision OncologyLONDON and HONG KONG, March 14, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:...
Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation
SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and...
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
Initiation of APEX Part 2 planned for mid-2023Updated clinical data from Phase 3 PEAK lead-in in GIST patients expected 1H23Initial...
Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging
Surgalign’s HOLO AI Insights aims to enhance clinical decision making through the power of AI technologyDEERFIELD, Ill., March 13, 2023...
VitalHub Announces Licensing of SHREWD Solution in Canada, With The Winnipeg Regional Health Authority
TORONTO, March 13, 2023 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce...
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures Ergo-Series...
Chiara Family Foundation Winter Classic hockey game raises $300,000 in support of the MUHC Foundation
Chiara Family Foundation Winter Classic hockey game raises $300,000 in support of the MUHC Foundation The game between Montreal Canadiens...
Adaptive Research and AHMC Seton Medical Center Announce Collaboration to Expand Clinical Trial Access to Both In- and Out-Patient Settings
SAN FRANCISCO and DALY CITY, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization...
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the...
Stereotaxis Reports 2022 Full Year Financial Results
ST. LOUIS, March 03, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas
Dr. Rick C. Sasso, renowned spinal surgeon to highlight Surgalign’s HOLO Portal™ Surgical Guidance System on the OrthoDome Panel on...
Philips showcases comprehensive cardiology portfolio designed to increase physician confidence and efficiency in diagnosing and treating cardiac disease at ACC/WCC 2023
Philips Intracardiac Echocardiography Catheter – VeriSight Pro Azurion image-guided therapy platform Philips Ultrasound Compact System 5500 CV Philips Spectral CT...
Detroit Pistons Become First Professional Sports Team in the United States to Partner with Progyny to Provide Comprehensive, Value-Based Family Building Care
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility...
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
Swoop® Portable MR Imaging® system positioned to offer even greater clinical utility in neurocritical careGUILFORD, Conn., Feb. 28, 2023 (GLOBE...
Scilex Holding Company announces the commercial launch of ELYXYBTM (celecoxib oral solution) in the U.S., strengthening its leadership position in non-opioid pain management
ELYXYBTM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or...
Cingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset CTx-1301 for ADHD
Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food CTx-1301 is Designed as a True, Entire Active-Day Treatment...
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
MENLO PARK, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on...
scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference
BURLINGTON, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
Microbot Medical’s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan
Allows Endovascular Procedure to be Performed from the Cath-Lab Control Room, Potentially Minimizing Radiation Exposure and Reducing Physical Strain for...